Table TDI-8. Primary use of stimulants of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (ii) All clients by country and type of stimulant (%)

Country		Amphetamines	%	Ecstasy	%	Other stimulants	%	Total
Belgium	(1)	472	89.2	50	9.5	7	1.3	529
Bulgaria		32	97.0	0	0.0	1	3.0	33
Czech Republic		4700	99.5	14	0.3	11	0.2	4725
Denmark		414	91.6	38	8.4	0	0.0	452
Germany	(2)	:	:	:	:	:	:	:
Estonia		11	100.0	0	0.0	0	0.0	11
Ireland		38	26.0	104	71.2	4	2.7	146
Greece		2	7.1	3	10.7	23	82.1	28
Spain	(3)	422	65.2	182	28.1	43	6.6	647
France		113	36.3	191	61.4	7	2.3	311
Italy		117	33.2	116	33.0	119	33.8	352
Cyprus		1	50.0	1	50.0	0	0.0	2
Latvia		112	87.5	6	4.7	10	7.8	128
Lithuania	(2)	:	:	:	:	:	:	:
Luxembourg		1	10.0	9	90.0	0	0.0	10
Hungary		330	86.8	42	11.1	8	2.1	380
Malta		0	0.0	19	100.0	0	0.0	19
Netherlands		606	84.3	77	10.7	36	5.0	719
Austria		68	66.0	25	24.3	10	9.7	103
Poland	(3 ; 4)	0	0.0	0	0.0	0	0.0	0
Portugal	(5)	:	:	:	:	:	:	:
Romania		5	22.7	17	77.3	0	0.0	22
Slovenia		0	0.0	2	100.0	0	0.0	2
Slovakia		545	99.6	2	0.4	0	0.0	547
Finland		395	95.6	4	1.0	14	3.4	413
Sweden		1890	99.3	12	0.6	1	0.1	1903
United Kingdom		4416	80.7	857	15.7	202	3.7	5475
Croatia		67	30.7	49	22.5	102	46.8	218
Turkey		1	2.0	50	98.0	0	0.0	51
Norway		:	:	:	:	:	:	:
Total		14758	85.7%	1870	10.9%	598	3.5%	17226

Notes:

 All types of treatment centres as defined by TDI Protocol 2.0 are included. 

 Percentages are of clients in treatment for stimulants as primary drug 

 (1) Last data available refer to 2005. Data do not cover Brussels Capital Region. 

 (2) For Germany and Lithuania only the aggregated data for Stimulants Total is available. Germany (4445 clients), Lithuania (153). 

 (3) Last data available refer to 2007.  

 (4) No breakdown by drug available 

 (5) Data for all clients is not available. 

 See also '‘General notes for interpreting data'’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2009 — Standard table 3. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)